Bacteriophage Therapy Trial
Phase 1
30
about 1.9 years
18+
2 sites in MO, TX
What this study is about
This trial is testing the safety of a phage treatment in adults with spinal cord injuries and bacteriuria. Participants will receive either phage therapy or a placebo for 696 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Phage Therapy
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: To evaluate the safety and tolerability of phage therapy in adults ≥18 years of age with spinal cord injury (SCI) and bacteriuria with Escherichia coli (E. coli)
Secondary: To evaluate of the pharmacodynamics (PD) of investigational phage therapy, To evaluate the pharmacokinetics (PK) of investigational phage therapy
Neurology